CNR1 and schizophrenia: As reviewed by Gouvêa et al. [34], although numerous association studies have explored the impact of CNR1 variability on schizophrenia, SSD, and other related clinical outcomes with largely negative results, the existing data is quite heterogeneous in terms of population origin and SNP selection.